Novozymes A/S
OTC:NVZMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novozymes A/S
OTC:NVZMY
|
DK |
|
Vimian Group AB
F:0V0
|
SE |
|
Coca Cola HBC AG
F:CCKC
|
CH |
|
Serco Group PLC
LSE:SRP
|
UK |
|
R
|
Roper Technologies Inc
XBER:ROP
|
US |
|
H
|
H & M Hennes & Mauritz AB
SWB:HMSB
|
SE |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
US |
|
S
|
Stora Enso Oyj
XBER:ENUR
|
FI |
|
Schneider Electric SE
PAR:SU
|
FR |
|
A
|
Adobe Inc
F:ADB
|
US |
Wall St Price Targets
NVZMY Price Targets Summary
Novozymes A/S
According to Wall Street analysts, the average 1-year price target for NVZMY is 72.93 USD with a low forecast of 59.04 USD and a high forecast of 89.16 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVZMY's stock price target?
Price Target
72.93
USD
According to Wall Street analysts, the average 1-year price target for NVZMY is 72.93 USD with a low forecast of 59.04 USD and a high forecast of 89.16 USD.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
